In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Photomedex Inc (NASDAQ:PHMD) reported that Pell Lewis C has picked up 424,064 of common stock as of 2017-05-01.
The acquisition brings the aggregate amount owned by Pell Lewis C to a total of 424,064 representing less than 9.7% stake in the company.
For those not familiar with the company, PhotoMedex, Inc. is a global health products and services company providing integrated disease management and solutions to dermatologists, professional aestheticians and consumers. The Company provides products and services that address skin diseases and conditions, including acne and photo damage. The Company operates through three business segments: Consumer segment, Physician Recurring segment and Professional segment. The Company provides skin health solutions to spa markets, as well as traditional retail, online and infomercial outlets for home-use products. The Company’s Consumer segment is engaged in the designing, development, manufacturing and selling of long-term hair reduction and acne consumer products. Its Physician Recurring segment is engaged in the sales of skincare products. Its Professional segment is engaged in the sale of equipment, such as medical and esthetic light and heat based products. Its LHE brands includes Mistral, Kona, FSD, SpaTouch Elite and accessories.
A glance at Photomedex Inc (NASDAQ:PHMD)’s key stats reveals a current market capitalization of 5.27 Million based on 4.36 Million shares outstanding and a price at last close of $1.26 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2012-06-14, Melumad picked up 1,000 at a purchase price of $10.57. This brings their total holding to 8,000 as of the date of the filing.
On the sell side, the most recent transaction saw Connelly unload 1,704 shares at a sale price of $2.61. This brings their total holding to 1,435.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Photomedex Inc (NASDAQ:PHMD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
